Moss, 2015 - Google Patents
A Perspective On Ionizing Radiation Exposure After The Japense Wake-Up Call-Part V-Protection From Radioactivity-Potasium Iodine and So Much More.Moss, 2015
- Document ID
- 17566389146416194371
- Author
- Moss J
- Publication year
- Publication venue
- Nutritional Perspectives: Journal of the Council on Nutrition
External Links
Snippet
The article presents a perspective on radiation exposure ionization one year after the tsunami in Japan on March 11, 2011. It provides update on the radioactive isotope exposure in the country, which serves as an indicator of an upper exposure limit in the US It discusses …
- 230000005865 ionizing radiation 0 title description 21
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Altagracia-Martínez et al. | Prussian blue as an antidote for radioactive thallium and cesium poisoning | |
| Scott | Health risk evaluations for ingestion exposure of humans to polonium-210 | |
| Farhood et al. | Selenium as an adjuvant for modification of radiation response | |
| Brugge et al. | Radium in the environment: exposure pathways and health effects | |
| Nikipelov et al. | Report on a radiological accident in the southern Urals on 29 September 1957 | |
| Prasad | Radiation injury prevention and mitigation in humans | |
| Moss | A Perspective On Ionizing Radiation Exposure After The Japense Wake-Up Call-Part V-Protection From Radioactivity-Potasium Iodine and So Much More. | |
| Le Guen et al. | French approach for the distribution of iodine tablets in the vicinity of nuclear power plants | |
| Bertho et al. | Co-exposure to internal and external radiation alters cesium biokinetics and retention in mice | |
| Ilyin et al. | Radioprotective drugs in the system of radiation protection of exposed radiation workers and population in the case of nuclear accidents | |
| Yadav et al. | Relevance Of Fukushima Nuclear Accident to India: Nuclear Radiation Risk and Interventions to Mitigate Adverse Fallout | |
| Garland | Medical Aspects of Hazards from Atomic Energy and its By-Products | |
| Medina et al. | Guidance For Industry | |
| Ashworth et al. | The Potential of Health Supplements to Mitigate the Detrimental Effects of Ionizing Radiation: A Systematic Review | |
| Piciu et al. | The radiation protection | |
| Popa et al. | STUDY ON PUBLIC PERCEPTION ABOUT POTASSIUM IODIDE (KI). | |
| Anca et al. | Study on public perception about potassium iodide (KI). | |
| Kato et al. | Murder With Radioactive Polonium Metal. | |
| Vetter et al. | Radiation and radioactivity | |
| Waghmare et al. | Lymphocyte Variation in Peripheral Blood of Mice with Low Level Gamma Irradiation | |
| Gachályi et al. | Effects of different decorporating agents on the whole–body retention of radioisotopes | |
| RU2521974C1 (en) | Method for radioactive substance washout from biological tissue with natural halogen-containing mineral water | |
| Dunn | The public health implications of the use of radioprotectors and radiomitigators in cumulative ionizing radiation exposure | |
| Zahriychuk | Ukrain, a thiophosphoric acid derivative of alkaloids of Chelidonium majus L., is effective in the treatment of recurrent bronchopulmonary pathology in children from areas contaiminated after the Chernobyl accident | |
| Martin | Scientific errors in published material concerning the radiation aspects of civil defence |